RhumbLine Advisers
GOSS icon

RhumbLine Advisers’s Gossamer Bio GOSS Stock Holding History

RhumbLine Advisers’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6K Sell
88,599
-127,797
-59% -$35.7K ﹤0.01% 3853
2026
Q1 		$71.2K Buy
216,396
+1,527
+0.7% +$2.4K ﹤0.01% 3517
2025
Q4 		$666K Sell
214,869
-10,191
-5% -$29.1K ﹤0.01% 2482
2025
Q3 		$592K Sell
225,060
-5,989
-3% -$13.2K ﹤0.01% 2578
2025
Q2 		$284K Buy
+231,049
New +$252K ﹤0.01% 3017
2024
Q3 		– Sell
-2,834
Closed -$2.55K – 4251
2024
Q2 		$2.55K Sell
2,834
-570
-17% -$426 ﹤0.01% 4164
2024
Q1 		$4.02K Hold
3,404
– – ﹤0.01% 4007
2023
Q4 		$3.11K Hold
3,404
– – ﹤0.01% 4048
2023
Q3 		$2.83K Sell
3,404
-4,405
-56% -$5.08K ﹤0.01% 4070
2023
Q2 		$9.37K Sell
7,809
-77,552
-91% -$96.6K ﹤0.01% 3967
2023
Q1 		$108K Buy
85,361
+1,344
+2% +$2.57K ﹤0.01% 2845
2022
Q4 		$182K Buy
84,017
+2,084
+3% +$17.2K ﹤0.01% 2815
2022
Q3 		$982K Buy
81,933
+8,283
+11% +$103K ﹤0.01% 2138
2022
Q2 		$616K Sell
73,650
-11,310
-13% -$87.6K ﹤0.01% 2384
2022
Q1 		$737K Sell
84,960
-6,304
-7% -$60.8K ﹤0.01% 2256
2021
Q4 		$1.03M Buy
91,264
+717
+0.8% +$8.52K ﹤0.01% 2190
2021
Q3 		$1.14M Buy
90,547
+3,223
+4% +$29.7K ﹤0.01% 2165
2021
Q2 		$709K Buy
87,324
+9,056
+12% +$78.5K ﹤0.01% 2406
2021
Q1 		$724K Sell
78,268
-4,040
-5% -$40.7K ﹤0.01% 2325
2020
Q4 		$796K Buy
82,308
+10,008
+14% +$98.6K ﹤0.01% 2248
2020
Q3 		$897K Sell
72,300
-5,795
-7% -$76.8K ﹤0.01% 2036
2020
Q2 		$1.01M Buy
78,095
+17,786
+29% +$224K ﹤0.01% 2037
2020
Q1 		$612K Buy
60,309
+3,030
+5% +$39.6K ﹤0.01% 2085
2019
Q4 		$895K Buy
57,279
+2,266
+4% +$45.6K ﹤0.01% 2134
2019
Q3 		$924K Buy
55,013
+31,453
+134% +$625K ﹤0.01% 2066
2019
Q2 		$523K Buy
23,560
+11,046
+88% +$211K ﹤0.01% 2345
2019
Q1 		$271K Buy
+12,514
New +$261K ﹤0.01% 2598

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

RhumbLine Advisers's GOSS Position: Q2 2026 in Review

RhumbLine Advisers reduced its Gossamer Bio (GOSS) stake by 59% in Q2 2026, selling an estimated $35.7K and leaving 88,599 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3853.

RhumbLine Advisers first reported a position in GOSS in Q1 2019 and has held it in 27 quarters since. The position peaked at $1.14M in Q3 2021. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • RhumbLine Advisers held 88,599 shares of Gossamer Bio worth $14.6K as of Q2 2026.
  • RhumbLine Advisers sold 127,797 Gossamer Bio shares in Q2 2026, an estimated $35.7K.
  • Gossamer Bio made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3853 holding.
  • RhumbLine Advisers first reported a position in Gossamer Bio in Q1 2019 and has held it in 27 quarters since.
  • RhumbLine Advisers's Gossamer Bio position peaked at $1.14M in Q3 2021.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.